Shobha Phansalkar

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
    Shobha Phansalkar
    Partners HealthCare Systems, Inc, Wellesley, MA 02481, USA
    BMC Med Inform Decis Mak 13:65. 2013
  2. pmc Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records
    Shobha Phansalkar
    Partners HealthCare Systems, Wellesley, MA 02481, USA
    J Am Med Inform Assoc 20:489-93. 2013
  3. pmc High-priority drug-drug interactions for use in electronic health records
    Shobha Phansalkar
    Division of General Internal Medicine and Primary Care, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Am Med Inform Assoc 19:735-43. 2012
  4. doi request reprint Understanding pharmacist decision making for adverse drug event (ADE) detection
    Shobha Phansalkar
    Brigham and Women s Hospital, Boston, MA, USA
    J Eval Clin Pract 15:266-75. 2009
  5. pmc A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems
    Shobha Phansalkar
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Am Med Inform Assoc 17:493-501. 2010
  6. doi request reprint Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools
    Adam Wright
    Brigham and Women s Hospital, 1620 Tremont Street, Boston, MA 02115, USA
    Am J Health Syst Pharm 69:221-7. 2012
  7. pmc Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support
    Hanna M Seidling
    Division of General Medicine and Primary Care, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Med Inform Assoc 18:479-84. 2011
  8. doi request reprint Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 30:2310-7. 2011
  9. pmc Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems--I-MeDeSA
    Marianne Zachariah
    Partners HealthCare System, Wellesley, Massachusetts 02481, USA
    J Am Med Inform Assoc 18:i62-72. 2011
  10. doi request reprint Design of decision support interventions for medication prescribing
    Jan Horsky
    Clinical Informatics Research and Development, Partners HealthCare, Boston, United States
    Int J Med Inform 82:492-503. 2013

Collaborators

Detail Information

Publications10

  1. pmc Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records
    Shobha Phansalkar
    Partners HealthCare Systems, Inc, Wellesley, MA 02481, USA
    BMC Med Inform Decis Mak 13:65. 2013
    ..The purpose of this study was to identify a set of criteria for assessing DDIs that should be used for the generation of clinical decision support (CDS) alerts in EHRs...
  2. pmc Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records
    Shobha Phansalkar
    Partners HealthCare Systems, Wellesley, MA 02481, USA
    J Am Med Inform Assoc 20:489-93. 2013
    ..The objective of this study is to report consensus-based recommendations of an expert panel on DDI that can be safely made non-interruptive to the provider's workflow, in EHR, in an attempt to reduce alert fatigue...
  3. pmc High-priority drug-drug interactions for use in electronic health records
    Shobha Phansalkar
    Division of General Internal Medicine and Primary Care, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Am Med Inform Assoc 19:735-43. 2012
    ..To develop a set of high-severity, clinically significant drug-drug interactions (DDIs) for use in electronic health records (EHRs)...
  4. doi request reprint Understanding pharmacist decision making for adverse drug event (ADE) detection
    Shobha Phansalkar
    Brigham and Women s Hospital, Boston, MA, USA
    J Eval Clin Pract 15:266-75. 2009
    ..As a first step to build such an expert system, this study explores pharmacist's decision-making processes for ADE detection...
  5. pmc A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems
    Shobha Phansalkar
    Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    J Am Med Inform Assoc 17:493-501. 2010
    ..We evaluate the limitations of current alerting philosophies and provide recommendations for improving acceptance of alerts by incorporating human factors principles in their design...
  6. doi request reprint Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools
    Adam Wright
    Brigham and Women s Hospital, 1620 Tremont Street, Boston, MA 02115, USA
    Am J Health Syst Pharm 69:221-7. 2012
    ..The results of a retrospective evaluation of the frequency and preventability of adverse drug events (ADEs) involving multiple drugs among hospital inpatients are reported...
  7. pmc Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support
    Hanna M Seidling
    Division of General Medicine and Primary Care, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Med Inform Assoc 18:479-84. 2011
    ..The clinical effectiveness of these systems, however, is substantially limited by poor user acceptance of presented warnings. To enhance alert acceptance it may be useful to quantify the impact of potential modulators of acceptance...
  8. doi request reprint Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 30:2310-7. 2011
    ..Even so, to limit liability in this area, we recommend stronger government regulation of clinical decision support systems and development of international practice guidelines highlighting the most important warnings...
  9. pmc Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems--I-MeDeSA
    Marianne Zachariah
    Partners HealthCare System, Wellesley, Massachusetts 02481, USA
    J Am Med Inform Assoc 18:i62-72. 2011
    ..Medication-related decision support can reduce the frequency of preventable adverse drug events. However, the design of current medication alerts often results in alert fatigue and high over-ride rates, thus reducing any potential benefits...
  10. doi request reprint Design of decision support interventions for medication prescribing
    Jan Horsky
    Clinical Informatics Research and Development, Partners HealthCare, Boston, United States
    Int J Med Inform 82:492-503. 2013
    ....